General Biomics and The Jackson Laboratory announce intellectual property licensing agreement

The agreement will aid in the understanding of the microbiome in human disease.

Gut microbes may help keep the blood-cerebrospinal fluid barrier intact

A recent study suggests that the blood-cerebrospinal fluid barrier is another barrier along the gut-brain axis that is likely influenced by the gut microbiota.

Microbiotas are transmitted between people that spend time together

A recent study suggests that people who spend time together share similar gut microbiotas — with some microbes being largely transmitted between friends and relatives.

Food and Food Supplements: As Italy, France Will Allow the Use of the Term ‘Probiotic’ Under Certain Conditions

The DGCCRF has announced that the use of the word “probiotic” can be allowed on the label of dietary supplements, as well as the health claim “contributes to the balance…

The Future of Microbiome Modulation Immuno-Oncology

Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.

EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer

First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg,…

New approach illuminates gut bacteria in living mice

The imaging approach can provide insights into the relationship between mice and their microbiota. It can also offer a glimpse of the cell wall turnover of gut bacteria in living…

Analysis of gut microbiota may predict disease severity in Chron’s patients

A recent study suggests that SCFA production is associated with a restoration of intestinal homeostasis and sustained remission in CD patients.

Bacthera And Capsugel Enprotect Capsule: From Complexity To Simplicity

Felix Faupel, Chief Commercial Officer at Bacthera, discussed how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market.

Micronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection

The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy with proven effectiveness, including identifying cancer in its earliest stages

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.